Best TWAS P=2.53e-16 · Best GWAS P=3.15e-18 conditioned to 2.28e-05
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | MED20 | 0.15 | 0.11 | blup | 471 | 0.13 | 3.1e-15 | -5.39 | 5.7 | 1.2e-08 | 0.61 | 1.00 | 0.00 | FALSE |
2 | GTEx | Adipose Subcutaneous | MED20 | 0.08 | 0.07 | enet | 9 | 0.05 | 4.7e-05 | 6.27 | 6.1 | 9.5e-10 | 0.61 | 0.96 | 0.01 | FALSE |
3 | GTEx | Adipose Subcutaneous | FRS3 | 0.15 | 0.04 | enet | 22 | 0.04 | 5.9e-04 | 8.02 | 5.4 | 7.4e-08 | 0.57 | 0.13 | 0.72 | FALSE |
4 | GTEx | Artery Tibial | MED20 | 0.14 | 0.11 | lasso | 2 | 0.09 | 9.7e-08 | 6.37 | 6.4 | 2.0e-10 | 0.60 | 0.99 | 0.01 | FALSE |
5 | GTEx | Cells Transformed fibroblasts | MED20 | 0.11 | 0.05 | lasso | 4 | 0.08 | 9.4e-07 | -6.73 | 6.9 | 4.4e-12 | 0.46 | 0.87 | 0.09 | FALSE |
6 | GTEx | Cells Transformed fibroblasts | USP49 | 0.13 | 0.02 | lasso | 4 | 0.02 | 2.4e-02 | -5.81 | -5.3 | 9.6e-08 | -0.37 | 0.29 | 0.03 | FALSE |
7 | GTEx | Colon Transverse | MED20 | 0.17 | 0.01 | enet | 10 | 0.06 | 6.0e-04 | 6.32 | 7.7 | 9.6e-15 | 0.69 | 0.18 | 0.59 | FALSE |
8 | GTEx | Esophagus Mucosa | MED20 | 0.09 | 0.07 | enet | 10 | 0.02 | 2.7e-02 | -5.39 | 5.7 | 1.3e-08 | 0.59 | 0.76 | 0.14 | FALSE |
9 | GTEx | Esophagus Muscularis | MED20 | 0.15 | 0.05 | lasso | 7 | 0.04 | 1.0e-03 | -5.32 | 6.4 | 2.1e-10 | 0.62 | 0.38 | 0.56 | FALSE |
10 | GTEx | Heart Atrial Appendage | MED20 | 0.14 | 0.12 | enet | 11 | 0.09 | 5.9e-05 | 6.19 | 5.9 | 3.8e-09 | 0.58 | 0.83 | 0.10 | FALSE |
11 | GTEx | Heart Left Ventricle | PRICKLE4 | 0.11 | 0.05 | lasso | 4 | 0.03 | 9.8e-03 | 6.23 | -6.2 | 4.9e-10 | -0.59 | 0.26 | 0.07 | FALSE |
12 | GTEx | Heart Left Ventricle | MED20 | 0.22 | 0.19 | enet | 8 | 0.12 | 5.8e-07 | 6.32 | 6.3 | 2.7e-10 | 0.61 | 1.00 | 0.00 | FALSE |
13 | GTEx | Lung | BYSL | 0.08 | 0.03 | lasso | 4 | 0.02 | 4.9e-03 | 8.33 | -7.5 | 5.5e-14 | -0.80 | 0.08 | 0.88 | FALSE |
14 | GTEx | Lung | USP49 | 0.09 | 0.08 | lasso | 2 | 0.05 | 6.2e-05 | -5.81 | -5.4 | 7.0e-08 | -0.33 | 0.84 | 0.01 | FALSE |
15 | GTEx | Muscle Skeletal | MED20 | 0.16 | 0.15 | lasso | 4 | 0.16 | 6.7e-16 | 6.23 | 6.3 | 3.2e-10 | 0.60 | 1.00 | 0.00 | FALSE |
16 | GTEx | Nerve Tibial | MED20 | 0.13 | 0.11 | enet | 8 | 0.10 | 1.5e-07 | 6.19 | 5.9 | 3.7e-09 | 0.58 | 1.00 | 0.00 | FALSE |
17 | GTEx | Spleen | MED20 | 0.44 | 0.13 | enet | 23 | 0.07 | 6.4e-03 | 6.37 | 6.2 | 5.3e-10 | 0.57 | 0.11 | 0.49 | FALSE |
18 | GTEx | Testis | MED20 | 0.13 | 0.03 | lasso | 6 | 0.00 | 2.0e-01 | -5.83 | 6.0 | 1.5e-09 | 0.46 | 0.15 | 0.18 | FALSE |
19 | GTEx | Thyroid | MED20 | 0.05 | 0.05 | lasso | 2 | 0.02 | 8.1e-03 | 6.44 | 6.4 | 1.8e-10 | 0.61 | 0.44 | 0.43 | FALSE |
20 | GTEx | Thyroid | FRS3 | 0.20 | 0.16 | lasso | 4 | 0.16 | 5.2e-12 | 8.02 | 7.2 | 5.8e-13 | 0.67 | 0.26 | 0.74 | FALSE |
21 | METSIM | Adipose | MED20 | 0.13 | 0.11 | enet | 27 | 0.11 | 2.3e-16 | 6.28 | 6.3 | 2.7e-10 | 0.61 | 1.00 | 0.00 | FALSE |
22 | ROSMAP | Brain Pre-frontal Cortex | PGC | 0.13 | 0.06 | blup | 520 | 0.06 | 3.2e-08 | 8.02 | -6.4 | 1.5e-10 | -0.58 | 0.17 | 0.83 | FALSE |
23 | ROSMAP | Brain Pre-frontal Cortex | MED20 | 0.10 | 0.10 | enet | 21 | 0.09 | 6.0e-12 | 6.44 | 6.1 | 1.3e-09 | 0.61 | 1.00 | 0.00 | FALSE |
24 | YFS | Blood | GUCA1B | 0.03 | 0.01 | bslmm | 402 | 0.01 | 1.4e-03 | 0.81 | -5.2 | 2.7e-07 | -0.15 | 0.30 | 0.02 | FALSE |
25 | YFS | Blood | MED20 | 0.04 | 0.03 | lasso | 5 | 0.03 | 3.6e-11 | 6.23 | 5.8 | 7.1e-09 | 0.61 | 1.00 | 0.00 | FALSE |
26 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | PRPH2 | 0.07 | 0.03 | enet | 6 | 0.06 | 1.9e-05 | 5.97 | -5.3 | 1.1e-07 | 0.03 | 0.00 | 0.99 | FALSE |
27 | The Cancer Genome Atlas | Breast Invasive Carcinoma | CCND3 | 0.04 | 0.00 | blup | 99 | 0.01 | 1.8e-03 | -5.74 | 6.2 | 7.4e-10 | 0.45 | 0.02 | 0.12 | FALSE |
28 | The Cancer Genome Atlas | Colon Adenocarcinoma | MED20 | 0.05 | 0.00 | blup | 50 | 0.04 | 2.8e-03 | 6.23 | 8.2 | 2.5e-16 | 0.70 | 0.06 | 0.32 | TRUE |
29 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | MED20 | 0.04 | 0.03 | lasso | 3 | 0.04 | 7.3e-05 | -6.73 | 6.7 | 2.0e-11 | 0.45 | 0.57 | 0.02 | FALSE |
30 | The Cancer Genome Atlas | Brain Lower Grade Glioma | MED20 | 0.09 | 0.08 | enet | 12 | 0.09 | 5.5e-10 | 6.37 | 7.2 | 5.0e-13 | 0.62 | 1.00 | 0.00 | FALSE |
31 | The Cancer Genome Atlas | Liver Hepatocellular Carcinoma | MED20 | 0.09 | 0.07 | lasso | 5 | 0.07 | 3.4e-04 | -5.83 | 6.9 | 6.8e-12 | 0.51 | 0.18 | 0.54 | FALSE |
32 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | UBR2 | 0.10 | 0.01 | blup | 77 | 0.04 | 9.1e-03 | 4.97 | -6.0 | 2.6e-09 | 0.01 | 0.01 | 0.61 | TRUE |
33 | The Cancer Genome Atlas | Prostate Adenocarcinoma | MED20 | 0.04 | 0.06 | enet | 6 | 0.05 | 2.6e-06 | 6.23 | 7.0 | 3.0e-12 | 0.58 | 0.90 | 0.02 | FALSE |
34 | The Cancer Genome Atlas | Stomach Adenocarcinoma | MED20 | 0.03 | 0.05 | lasso | 2 | 0.04 | 1.2e-03 | -6.73 | 6.7 | 2.4e-11 | 0.44 | 0.11 | 0.06 | FALSE |
35 | The Cancer Genome Atlas | Thyroid Carcinoma | BYSL | 0.05 | 0.06 | enet | 7 | 0.06 | 4.3e-06 | 6.44 | -6.0 | 2.5e-09 | -0.56 | 0.83 | 0.09 | FALSE |